コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 NICU treatments used to improve neurodevelopmental outco
4 tational age (OR = 1.10; 95% CI, 1.05-1.16), NICU admission (OR = 1.12; 95% CI, 1.07-1.17), hyperbili
6 1.8% vs 17.2%; RR, 1.48; 95% CI, 1.00-2.19), NICU admission (12.1% vs 17.7%; RR, 1.54; 95% CI, 1.05-2
8 gar score less than 7 (RR 2.11 [1.03-4.29]), NICU admission (RR 3.34 [1.61-6.9]) and Neonatal Near Mi
11 ole-genome sequencing (STATseq) in a level 4 NICU and PICU to assess the rate and types of molecular
14 pidemiologique de la flore), in 20 of the 64 NICUs, analyzed the intestinal microbiota by culture and
16 t-level demographic and outcomes data from 8 NICUs who were long term CQI collaborators within the Ve
17 Hospital length of stay increased in the 8 NICUs 64 to 71 days (P <.001), and a similar increase wa
18 based analyses were performed in 29/32 (91%) NICU newborns and 6/127 (5%) healthy newborns who later
19 9% vs 2.5%; adjusted odds ratio [OR], 1.92), NICU or neonatology service admission (8.8% vs 5.3%; adj
20 l containment of an adenovirus outbreak in a NICU associated with contaminated handheld ophthalmologi
21 ing the study period, newborns admitted to a NICU were larger and less premature, although no consist
22 are increasingly likely to be admitted to a NICU, which raises the possibility of overuse of neonata
25 investigate the impact of cleaning within a NICU, a high-throughput short-amplicon-sequencing approa
26 fants included, 6.6% received care in type A NICUs with restrictions, 29.3% in type A NICUs without r
27 e A NICUs with restrictions, 29.3% in type A NICUs without restrictions, 39.7% in type B NICUs, and 2
30 onatal intensive care unit (NICU) admission, NICU length of stay, hyperbilirubinemia, respiratory dis
32 centers reporting that more than 20% of all NICU days were attributed to the care of these infants i
33 parents of sick children and who were also "NICU parents." We have developed an etiquette-based syst
34 h very low birth weight (below 1500 g) among NICUs with various levels of care and different volumes
35 cal and molecular epidemiology of MRSA in an NICU between 2003 and 2013, in the decade following the
38 ficantly different from hospitals without an NICU, and was significantly higher than hospitals with l
41 gnancy (RR, 1.32 [1.08-1.60], p < 0.01), and NICU admission among women exposed to gabapentin both ea
43 life environment factors (breast-feeding and NICU admission) might contribute to EoE susceptibility.
44 atory complications, hyperbilirubinemia, and NICU admission, were increased in association with mater
45 = .02) and rs17815905 (LOC283710/KLF13) and NICU admission (P = .02) but not with any of the factors
46 <34 weeks), the number of neonatologist and NICU beds, 25.2% and 58.7% of the HSA-level variance in
49 ), but resulted in less probability that any NICU infant received a lumbar puncture (p = .0001) or pe
51 spital with a level III NICU with an average NICU census of at least 15 patients per day had signific
57 nfants born at hospitals with a level IIIB/C NICU and lowest among infants born at hospitals with a l
62 ematurely and/or with medical complications (NICU children) and 25 control children born at term were
64 general" combined outcome (preterm delivery, NICU, SGA); and "severe" combined outcome (early preterm
68 the odds ratio (95% confidence interval) for NICU admission was 2.14 (1.01 to 4.54); for a length of
70 ission (p = .003) and a 12% greater risk for NICU discharge (p = .02) were found in the after period
71 rm births (38.4%) and increased the risk for NICU or neonatology service admission (12.2%) and morbid
73 nient access to maternal health services for NICU mothers should be explored to reduce adverse matern
74 first, to our knowledge, web-based tool for NICUs to calculate their own composite morbidity and res
76 care unit/neonatal intensive care unit (ICU/NICU) admissions (OR = 1.5; CI, 1.4-1.6; P < .0001) were
80 fants born at hospitals with a level I or II NICU compared with infants delivered at hospitals with a
81 k for developing BPD was higher for level II NICUs (odds ratio, 1.23; 95% CI, 1.02-1.49) and similar
82 vel III NICUs, and in level II+ and level II NICUs, regardless of size, was not significantly differe
83 er of hospitals that could provide level III NICU care has the potential to decrease neonatal mortali
84 infants born in a hospital with a level III NICU with an average NICU census of at least 15 patients
86 fants born at hospitals with large level III NICUs were not more than those for infants born at other
87 tality for infants born in smaller level III NICUs, and in level II+ and level II NICUs, regardless o
90 pitals (low-volume level IIIB and level IIIA NICUs) had odds of death ranging from 1.42 (95% CI, 1.08
93 mework for precision medicine for infants in NICU and PICU who are diagnosed with genetic diseases to
94 nosocomial bacteraemia was less frequent in NICUs with low neonatal consultant provision (odds ratio
95 edominant mode of acquisition by neonates in NICUs at this hospital; mothers may be colonized with mu
101 8 drugs studied in neonates were not used in NICUs; 8 (29%) were used in fewer than 60 neonates.
102 r the support and survival of these infants, NICU sensory environments are dramatically different fro
104 ediate NICU: level II; expanded intermediate NICU: level II+: tertiary NICU: level III) and by the av
105 re available (no NICU: level I; intermediate NICU: level II; expanded intermediate NICU: level II+: t
111 , relative mortality reduction 21%) and mean NICU LOS from 3.5 to 2.9 days (95% confidence interval,
114 fied by the level of NICU care available (no NICU: level I; intermediate NICU: level II; expanded int
116 the risk of death during the first 3 days of NICU admission (p = .003) and a 12% greater risk for NIC
121 Hospitals were classified by the level of NICU care available (no NICU: level I; intermediate NICU
122 takeholders acknowledged the unique needs of NICU mothers and cited system challenges, lack of clarit
123 al workload was operationalized as number of NICU infants cared for by the individual houseofficer on
124 that increased clinical workload (number of NICU infants) resulted in a significantly greater probab
125 ie (birth weight < 751 g), the percentage of NICU bed-days allocated to nonsurviving infants was less
126 significantly larger than the percentage of NICU bed-days devoted to nonsurviving babies (7.8%).
129 es (6.8%) had a significantly higher rate of NICU or neonatology service admission compared with term
133 5 and the number of years it took for 75% of NICUs to achieve the 2005 rates from the best quartile w
135 means of managing the microbial ecosystem of NICUs and of future opportunities to minimize exposures
136 1980s, coinciding with the establishment of NICUs and the increasing use of vancomycin in these unit
137 In this review we focus on the impact of NICUs in tissue physiology and how this fast-evolving fi
139 ry studies on neonates admitted to operating NICUs demonstrate performance comparable to the most adv
142 ssociated with higher risks for prematurity, NICU admission, and SGA status compared with longer inte
151 virus identified from any clinical specimen (NICU patient or employee) or compatible illness in a fam
155 nts without diagnosed BPD, and six full-term NICU patients (gestational ages, 23-39 wk) at near term-
156 anded intermediate NICU: level II+: tertiary NICU: level III) and by the average patient census in th
165 rd genetic testing in a case series from the NICU and PICU of a large children's hospital between Nov
169 after period, fewer of them occurred in the NICU (odds ratio, 0.2; 95% confidence interval, 0.08 to
170 5 p = .017, respectively) and for men in the NICU (r = .55, p = .003) and the SICU (r = .29, p = .036
171 relationships between procedural pain in the NICU and early brain development in very preterm infants
174 The clinical workload of housestaff in the NICU can affect decisions to perform procedures on infan
177 al opportunistic yeasts were detected in the NICU environment, demonstrating that these NICU surfaces
179 who acquired C. albicans colonization in the NICU had C. albicans-positive mothers; specimens from al
182 e 42 studies that discussed GS and ES in the NICU setting, six themes were identified: disease detect
183 of an infant to a specific antibiotic in the NICU was not a risk factor for the carriage of a strain
195 e average severity-of-illness of each of the NICU infants, the experience and residency program of th
196 ted an antibiogram identical to those of the NICU isolates, all 24 strains could be distinguished fro
197 l by neonatologists and other members of the NICU team would likely result in a significant increase
198 receiving increased antibiotics while on the NICU did not significantly impact the microbiome PD.
201 s on the CANTAB subscales indicated that the NICU children had a shorter spatial memory span length a
203 mples collected from infants admitted to the NICU for suspected sepsis were analyzed for bacterial gr
206 disposition of all patients admitted to the NICU were compared between two 19-month periods, before
208 95% CI, 0.90 to 1.63), and admission to the NICU with moderate-to-severe hypoxic-ischemic encephalop
210 ckground), 1243 (88.5%) were admitted to the NICU; 490 of 546 infants (89.7%) born to mothers with a
211 nfants; neurobehavior was assessed using the NICU Network Neurobehavioral Scales (NNNS) in an indepen
214 st 1 corticosteroid of interest during their NICU stay, including 279 exposed to dexamethasone, 137 e
218 loci differed between infants based on their NICU Network Neurobehavioral Scale (NNNS) profile classi
219 e NICU environment, demonstrating that these NICU surfaces represent a potential vector for spreading
223 perinatal databases, and data pertaining to NICU or neonatology service admissions were extracted fr
228 endently, showing parallel evolution towards NICU specialization and non-susceptibility to vancomycin
230 e prematurity, neonatal intensive care unit (NICU) admission, congenital malformation, small for gest
231 resuscitation, neonatal intensive care unit (NICU) admission, NICU length of stay, hyperbilirubinemia
232 the following: neonatal intensive care unit (NICU) admission, surfactant, assisted ventilation, antib
237 babies in the neonatal intensive care unit (NICU) face a host of challenges following childbirth.
239 erm gut on the neonatal intensive care unit (NICU) impacted the gut microbiota and metabolome long-te
240 infants in the neonatal intensive care unit (NICU) is associated with adverse events, including fever
241 the impact of neonatal intensive care unit (NICU) level on moderate and late preterm (MLP) care qual
243 collected from neonatal intensive care unit (NICU) patients within 7 days of discontinuation of thera
244 systems in the neonatal intensive care unit (NICU) require multiple wires connected to rigid sensors
246 lation between neonatal intensive care unit (NICU) strategies concerning the rate of progression of e
247 mission to the neonatal intensive care unit (NICU) with moderate-to-severe hypoxic-ischemic encephalo
248 dmitted to the neonatal intensive care unit (NICU), and one of them had bilateral hearing impairment.
249 ner within our neonatal intensive care unit (NICU), diagnostic-quality MRIs using commercially availa
250 ction with the neonatal intensive care unit (NICU), it is often not because they think their baby has
251 fection in the neonatal intensive care unit (NICU), often associated with significant morbidity.
252 institutional neonatal intensive care unit (NICU), whose gestational age at birth was 30 or more wee
260 SGA); need for neonatal intensive care unit (NICU); new onset of hypertension; new onset/doubling of
262 d death in the neonatal intensive care unit [NICU]) after the first 50 neonates were enrolled, then a
263 admission to a neonatal intensive care unit [NICU]) of patients who received antenatal chemotherapy w
264 eonatal and paediatric intensive care units (NICU and PICU) is not sufficiently timely to guide acute
267 neonatal and pediatric intensive-care units (NICUs and PICUs, respectively) involves continuous monit
268 mitted to 290 neonatal intensive care units (NICUs) (the Pediatrix Data Warehouse) in the United Stat
271 re infants in neonatal intensive care units (NICUs) are highly susceptible to infection due to the im
272 adenovirus in neonatal intensive care units (NICUs) can lead to widespread transmission and serious a
274 st that large neonatal intensive-care units (NICUs) have better outcomes than small units, although t
275 proportion of neonatal intensive care units (NICUs) in 2014 that achieved rates for death and major m
276 the number of neonatal intensive care units (NICUs) in community hospitals and the complexity of the
279 361) from 32 neonatal intensive care units (NICUs) in the United States were randomly assigned to re
282 difficult for neonatal intensive care units (NICUs) to determine the overall efficacy of multiple con
284 surveys from neonatal intensive care units (NICUs), offices and molecular biology laboratories, and
288 ss the importance of neuroimmune cell units (NICUs) in intestinal development, homeostasis and diseas
289 sensed by discrete neuro-immune cell units (NICUs), which represent defined anatomical locations in
290 Data were collected from all infants until NICU discharge or death (last day of data collected, Dec
291 dy included 972 VLBW infants treated in 6 US NICUs, with admission dates from January 1, 2006, to Dec
298 eight deliveries occurred in facilities with NICUs that offered a high level of care and had a high v
299 r deliveries that occurred in hospitals with NICUs that had both a high level of care and a high volu